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Abstract
Background: Individuals differ in the response to regular exercise. Whether there are people who experience adverse
changes in cardiovascular and diabetes risk factors has never been addressed.
Methodology/Principal Findings: An adverse response is defined as an exercise-induced change that worsens a risk factor
beyond measurement error and expected day-to-day variation. Sixty subjects were measured three times over a period of
three weeks, and variation in resting systolic blood pressure (SBP) and in fasting plasma HDL-cholesterol (HDL-C),
triglycerides (TG), and insulin (FI) was quantified. The technical error (TE) defined as the within-subject standard deviation
derived from these measurements was computed. An adverse response for a given risk factor was defined as a change that
was at least two TEs away from no change but in an adverse direction. Thus an adverse response was recorded if an increase
reached 10 mm Hg or more for SBP, 0.42 mmol/L or more for TG, or 24 pmol/L or more for FI or if a decrease reached
0.12 mmol/L or more for HDL-C. Completers from six exercise studies were used in the present analysis: Whites (N = 473)
and Blacks (N = 250) from the HERITAGE Family Study; Whites and Blacks from DREW (N = 326), from INFLAME (N = 70), and
from STRRIDE (N = 303); and Whites from a University of Maryland cohort (N = 160) and from a University of Jyvaskyla study
(N = 105), for a total of 1,687 men and women. Using the above definitions, 126 subjects (8.4%) had an adverse change in FI.
Numbers of adverse responders reached 12.2% for SBP, 10.4% for TG, and 13.3% for HDL-C. About 7% of participants
experienced adverse responses in two or more risk factors.
Conclusions/Significance: Adverse responses to regular exercise in cardiovascular and diabetes risk factors occur.
Identifying the predictors of such unwarranted responses and how to prevent them will provide the foundation for
personalized exercise prescription.
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Introduction
Physical activity level and cardiorespiratory fitness are strongly
and inversely associated with the risk of cardiovascular-, metabol-
ic-, and aging-related morbidities, as well as premature mortality
[1]. To alleviate the health burden associated with sedentary
behavior and poor fitness, public health recommendations are that
adults be physically active at a moderate intensity for 150 minutes
per week or at a vigorous intensity for 75 minutes per week [2].
However, there is considerable interindividual variability in the
ability to improve one’s cardiorespiratory fitness and cardiometa-
bolic and diabetes risk factor profile in response to regular
exercise. This clear finding of the HERITAGE Family Study has
been replicated [3,4,5,6]. A fundamental question is whether there
are individuals who experience one or several adverse responses
(ARs) in terms of exercise-induced changes in common risk factors.
This issue is addressed herein based on data from six exercise
intervention studies, with a focus on exercise-induced changes in
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resting systolic blood pressure (SBP), fasting insulin (FI), HDL-
cholesterol (HDL-C), and triglycerides (TG). The studies used for
this purpose are: HERITAGE Family Study (HERITAGE),
DREW, INFLAME, STRRIDE, University of Maryland Gene
Exercise Research Study (MARYLAND), and University of
Jyva¨skyla¨ study (JYVASKYLA).
Methods
Data on a maximum of 1687 adults from six studies were
available for analysis. These studies will be briefly described,
followed by the definition of AR and the statistical procedures
employed. More information on each study is available in
Information S1.
HERITAGE (Health, Risk Factors, Exercise Training And
Genetics) Family Study
The sample, study design, and exercise training protocol of
HERITAGE have been described elsewhere [7]. Briefly, 473
adults from 99 families of Caucasian descent and 250 Blacks from
105 families or sibships completed the 20-week endurance training
program. Parents were 65 years of age or less while offspring
ranged in age from 17 to 41 years.
Dose Response to Exercise in Women (DREW) Study
A complete description of the DREW design and methods and
details of the study participants have been published [8]. In brief, it
was a randomized, dose-response exercise trial with sedentary, high-
normal blood pressure, postmenopausal, overweight or obese
women (N=326: 63% White) assigned to either a nonexercise
control group or to endurance exercise groups that expended 4, 8,
or 12 kcal/kg of body weight per week for a period of 6 months [6].
Inflammation and Exercise (INFLAME) Study
Sedentary men and women between the ages of 30 and 75 years
who had an elevated plasma C-reactive protein (CRP) concentra-
tion ($2.0 mg/L but ,10.0 mg/L) were randomized to an
endurance exercise or a control group [9]. Completers (70%
Whites) exercised a mean of 204 minutes per week.
Studies of a Targeted Risk Reduction Intervention
through Defined Exercise (STRRIDE)
STRRIDE (84% Whites) includes two complementary studies
[10,11]. STRRIDE was composed of 40- to 65-year-old, sedentary,
overweight or class 1 obese (BMI 25–35 kg/m2), dyslipidemic men
and women. They were assigned to one of three aerobic exercise
groups and exercised for 6 months. The STRRIDE aerobic training
Table 1. Reproducibility of Risk Factors from Measurements Repeated Over 3 Days on 60 Subjects.
Variable Mean ± SD (at first test) CV ICC TE
Stature, cm 171.768.3 0.2 1.00 0.3
Body weight, kg 71.5612.8 0.9 1.00 0.7
Fasting insulin*, pmol/L 65.8640.0 19–29 0.78–0.94 13.2–19.8 (12)
HDL-C, mmol/L 1.0860.25 6.0 0.94 0.06
Triglycerides, mmol/L 1.0460.47 21.8 0.79 0.21
Systolic BP, mm Hg 118.7610.3 4.1 0.76 4.9
ICC = intraclass correlation computed from the within-subject variance compared to the overall measurement variance.
TE = technical error defined by the within-subject standard deviation calculated from repeated measurements. It includes a combination of measurement error plus day-
to-day variation.
CV = Coefficients of variation is expressed as a percentage and is derived from the technical error and the measurement mean.
*Note on insulin: The values reported here are from the repeated measurements obtained at baseline (N = 779) and after (N = 624) the exercise program in HERITAGE
(Information S1). The TE used for this report is shown in parentheses.
To convert pmol/L of insulin to mU/L, divide by 6.945. To convert mmol/L of HDL-C to mg/dL, divide by 0.02586. To convert mmol/L of triglycerides to mg/dl, divide by
0.01129.
doi:10.1371/journal.pone.0037887.t001
Table 2. Descriptive Data, Including Baseline V˙O2max and its Response to Training, for the Six Cohorts.
HERITAGE
Whites
HERITAGE
Blacks DREW INFLAME STRRIDE MARYLAND JYVASKYLA
Maximum number of subjects 473 250 326 70 303 160 105
Age, yrs 35.8 (14.5) 33.6 (11.5) 57.9 (6.5) 51.2 (10) 51.0 (7.7) 58.0 (5.8) 53.5 (7.6)
Baseline BMI, kg/m2 25.8 (4.9) 27.8 (5.8) 31.5 (3.9) 31.1 (4.3) 29.9 (2.9) 28.3 (4.6) 25.4 (3.1)
Baseline
V˙O2max, mL/min
2458 (740) 2086 (629) 1312 (240) 1629 (567) 2466 (694) 2060 (536) 2262 (616)
Baseline
V˙O2max, mL/kg/min
33.2 (8.9) 27.3 (7.3) 15.8 (2.5) 19.0 (5.6) 28.2 (6.0) 25.3 (4.6) 29.8 (6.2)
V˙O2max response, mL/min 395 (215) 362 (171) 108 (132) 204 (213) 281 (273) 250 (228) 259 (223)
V˙O2max response, % 16.9 (9.0) 18.9 (10.3) 8.7 (10.5) 14.1 (13.5) 12.0 (12.0) 12.3 (10.1) 13.0 (11.7)
Values are given as mean (SD). V˙O2max response = post-training V˙O2max minus baseline V˙O2max (positive value represents improvement in V˙O2max).
All gains in VO2max are significant at p,0.05.
doi:10.1371/journal.pone.0037887.t002
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versus resistance training (AT/RT) cohort was very similar to
STRRIDE, but only those who were enrolled in endurance exercise
programs are included in the present report.
University of Maryland Gene Exercise Research Study
(MARYLAND)
Briefly, 160 men and women (100% Whites) ages 50 to 75 years
who were sedentary, nondiabetic, and nonsmoking, with no prior
history of cardiovascular disease but with one National Cholesterol
Education Program lipid abnormality or blood pressure in the
prehypertensive range, exercised three times per week for a period
of 6 months [12].
University of Jyva¨skyla¨ Study (JYVASKYLA)
Healthy, sedentary 40- to 67-year-old men and women were
recruited [13]. A total of 206 subjects were randomized to one of
four groups. Here we used the data on 25 men and 26 women of
the endurance training group and on 30 men and 24 women (all
Whites) of the combined endurance and strength training group
who exercised for 21 weeks.
Definition of adverse responses
For the four traits studied, some subjects experienced changes in
an opposite, unfavorable direction compared to the expected
beneficial effects. This is analogous to an AR pattern. Defining an
AR for any given risk factor is a challenge. A robust definition
takes into account the measurement error of the trait, including
the variance among laboratories or laboratory technicians, and the
normal day-to-day biological variation of the trait. The parameter
that captures the totality of these sources of variance in a trait is
known as the technical error (TE), defined as the within-subject
standard deviation as derived from repeated measures (or assays)
over a given period of time, as used in the National Health and
Nutrition Examination Survey (NHANES) [14]. An ancillary
study designed to quantify TE for several biological traits was
undertaken in HERITAGE. Sixty subjects were measured three
times (except for FI) over a period of 3 weeks for each trait
[15,16,17,18,19]. TEs and other useful indicators of reproducibil-
ity are shown in Table 1. In the case of FI, the assays were
performed only twice, and we used other HERITAGE data plus
observations from the literature to develop an estimate of TE for
FI (Information S1). Here, we have conservatively defined an AR
as a response beyond 26TE in a direction indicating a worsening
of the risk factor. For the four traits in the present study, twice the
value of TE would mean that ARs would be reached if the exercise
training-induced increases are $10 mm Hg for SBP,
$0.42 mmol/L for plasma TG, and $24 pmol/L for plasma FI
or if there is a decrease of #0.12 mmol/L for HDL-C. These AR
definitions are used in the remainder of this report.
Statistical procedures
Data are expressed as means and standard deviations or
standard errors as specified. Intraclass correlations were computed
from the within-subject variance relative to the overall measure-
ment variance. The coefficient of variation is expressed as a
percentage and is derived from the TE relative to the measure-
ment mean. The significance of the gains in VO2max and of the
mean changes in the four targeted risk factors within each cohort
was assessed with paired t tests. The comparisons of VO2max
gains between adverse responders and non-adverse responders for
each risk factor trait for each study was undertaken as follows: The
difference between the changes in VO2max with exercise training
expressed in ml O2 per minute was tested with the general linear
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model and is reported as least squares (LS) means with age, sex,
and baseline VO2max as covariates. The gain in VO2max % is
reported as LS means with age and sex as covariates.
Results
Subjects in DREW, INFLAME, STRRIDE, MARYLAND, and
JYVASKYLA were about 20 years older than HERITAGEWhites
and Blacks (Table 2). All cohorts had a mean BMI in the overweight
range (i.e.,.25.0 but,30.0 kg/m2), with the exception of DREW
and INFLAME, with mean values of about 31 kg/m2. Mean
baseline VO2max was considerably lower in DREW and
INFLAME compared to the other studies. The mean increase in
VO2max (ml O2 per minute) ranged from 108 (DREW) to 395
(HERITAGE Whites). The percent increase of VO2max ranged
from 8.7% (DREW) to 18.9% (HERITAGE Blacks).
Baseline values and the mean (6SD) changes of the risk factors
in response to exercise programs are shown in Table 3 for each
Figure 1. Distribution of the response to the HERITAGE exercise program with adverse responders highlighted in red. To convert
pmol/L of insulin to mU/L, divide by 6.945. To convert mmol/L of HDL-C to mg/dL, divide by 0.02586. To convert mmol/L of triglycerides to mg/dl,
divide by 0.01129.
doi:10.1371/journal.pone.0037887.g001
Table 4. Prevalence of Adverse Responders in HERITAGE.
HERITAGE Whites (#473) HERITAGE Blacks (#250)
Risk factor 26TE N % N %
D Fasting insulin N$24 pmol/L 38 9 17 9
D HDL-C N#0.12 mmol/L 28 6 19 8
D Triglycerides N$0.42 mmol/L 37 8 19 8
D Systolic BP N$10 mm Hg 28 6 16 7
To convert pmol/L of insulin to mU/L, divide by 6.945. To convert mmol/L of HDL-C to mg/dL, divide by 0.02586. To convert mmol/L of triglycerides to mg/dl, divide by
0.01129.
doi:10.1371/journal.pone.0037887.t004
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cohort. There was a wide range of baseline values for all risk
factors. For instance, mean baseline HDL-C levels ranged from
1.04 mmol/L (HERITAGE Whites) to about 1.50 mmol/L
(INFLAME and all DREW exercise groups). The mean changes
induced by the exercise programs were generally in the expected
direction (i.e., decreases in FI, TG, and SBP and increases in
HDL-C). There were, however, some statistically nonsignificant
exceptions to these general trends.
Using the definitions outlined in Table 1, the prevalence of ARs
for the four risk factors was first explored in the 473 Whites and
250 Blacks of HERITAGE who were all exposed to the same
standardized exercise programs and were all qualified as
completers. The results are depicted in Figure 1 and are
summarized in Table 4. Although HERITAGE subjects were
apparently healthy and not taking medication for blood pressure,
glucose, or lipid anomalies and were exposed to the same exercise
program, 6% to 9% of Blacks and Whites experienced ARs for
each of the four risk factors, with no substantive differences
between the two ethnic groups.
To gain a better understanding of the true prevalence of ARs
for each risk factor, we compared the data obtained in
HERITAGE with those of five other exercise training studies.
The results are summarized in Table 5. It is quite obvious that the
findings in HERITAGE are not unique to the HERITAGE
subjects and exercise protocol. Based on a maximum of 1687
subjects, the prevalence of an AR reached 8.3% for the changes in
FI, 13.3% for the changes in fasting HDL-C, 10.3% for TG, and
12.2% for resting SBP. The percentages of adverse responders for
each trait for each study are depicted in Figure 2. It is remarkable
that such cases were found in each study, even though the age and
health status of the subjects were widely divergent and the exercise
programs were quite heterogeneous.
Figure 2. Percentages of adverse responders for each risk factor trait by study, with number of adverse responder subjects in each
bar.
doi:10.1371/journal.pone.0037887.g002
Table 5. Prevalence of Adverse Responders to Regular Exercise in Six Studies.
HERITAGE DREW INFLAME STRRIDE MARYLAND JYVASKYLA TOTAL %*
N subjects #723 #326 #70 #303 #160 #105 #1687
D Fasting insulin 55 36 12 17 4 2 126 8.3
D HDL-C 47 87 21 32 8 27 222 13.3
D Triglycerides 56 51 9 34 11 11 172 10.3
D Systolic BP 44 58 11 NA 43 10 166 12.2
*% represents the proportion of adverse responders in relation to the total number of subjects exercise trained for each of the four traits.
doi:10.1371/journal.pone.0037887.t005
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One important question to consider is whether those who
respond adversely for a given risk factor are also those who
experience the least improvement in cardiorespiratory fitness with
regular exercise. This question was addressed by comparing the
gains in VO2max between the subgroups of adverse responders and
non-adverse responders for a given risk factor. The results of these
analyses are shown in Table 6 for the gains in ml O2 per minute and
the percentage increases in VO2max. A total of 56 differences were
tested with age, sex, and baseline VO2max as covariates for the gain
in ml O2 per minute and age and sex for the percentage increase.
Only two such differences reached the 0.05 level of significance, and
they were far from reaching a multiple test Bonferroni adjusted P
value of 0.0009. These data indicate that AR traits are independent
of the improvement in cardiorespiratory fitness.
One could hypothesize that the proportion of ARs should decrease
as the amount of exercise increases.We tested this hypothesis with the
Table 6. Comparison of the VO2max response to regular exercise between adverse responders and non-adverse responders for
each response trait in each study.
HERITAGE Whites HERITAGE Blacks DREW INFLAME
Adverse
responders
Non-adverse
responders
Adverse
responders
Non-adverse
responders
Adverse
responders
Non-adverse
responders
Adverse
responders
Non-adverse
responders
D Fasting insulin
N subjects 38 411 17 184 36 290 12 58
D VO2max (ml/min) 382 (34) 399 (10) 472 (43) 385 (14) 76 (22) 69 (7) 99 (61) 226 (28)
D VO2max (%) 16.1 (1.4) 17.0 (0.4) 20.6 (2.5) 18.3 (0.8) 6.0 (1.7) 5.8 (0.6) 8.0 (3.4) 14.5 (1.6)
D HDL-C
N subjects 28 443 19 220 87 239 21 49
D VO2max (ml/min) 384 (40) 400 (10) 348 (39) 388 (12) 68 (14) 71(8) 219 (48) 196 (32)
D VO2max (%) 16.2 (1.7) 17.0 (0.4) 15.5 (2.3) 18.4 (0.7) 5.4 (1.1) 6.0 (0.7) 14.2 (2.7) 12.9 (1.8)
D Triglycerides
N subjects 37 434 19 220 51 275 9 61
D VO2max (ml/min) 424 (34) 397 (10) 332 (39) 392 (13) 72 (18) 70 (8) 136 (72) 213 (28)
D VO2max (%) 17.7 (1.4) 16.9 (0.4) 16.9 (2.3) 18.3 (0.7) 6.1 (1.5) 5.8 (0.6) 8.6 (4.0) 14.0 (1.6)
D Systolic BP
N subjects 28 442 16 220 58 268 11 59
D VO2max (ml/min) 348 (40) 401 (10) 396 (42) 386 (12) 60 (17) 72 (8) 140 (65) 215 (28)
D VO2max (%) 14.8 (1.7) 17.0 (0.4) 16.7 (2.5) 18.2 (0.7) 4.9 (1.4) 6.1 (0.6) 7.5 (3.6) 14.4 (1.6)
STRRIDE MARYLAND JYVASKYLA
Adverse
responders
Non-adverse
responders
Adverse
responders
Non-adverse
responders
Adverse
responders
Non-adverse
responders
D Fasting insulin
N subjects 17 286 4 92 2 57
D VO2max (ml/min) 278 (102) 278 (16) 112 (102) 306 (21) 340 (158) 277 (30)
D VO2max (%) 10.5 (3.6) 11.7 (0.7) 7.7 (5.0) 15.1 (1.0) 12.7 (8.8) 14.2 (1.6)
D HDL-C
N subjects 32 271 8 142 26 71
D VO2max (ml/min) 231 (41) 281 (17) 206 (72) 274 (17) 183 (42){ 287 (26)
D VO2max (%) 11.4 (2.6) 11.6 (0.7) 10.0 (3.4) 13.4 (0.8) 8.1 (2.2){ 14.7 (1.3)
D Triglycerides
N subjects 34 269 11 141 11 86
D VO2max (ml/min) 201 (46) 281 (17) 276 (62) 272 (17) 285 (67) 256 (24)
D VO2max (%) 8.3 (1.9) 12.1 (0.7) 13.4 (3.0) 13.3 (0.8) 12.3 (3.5) 13.0 (1.3)
D Systolic BP
N subjects N/A N/A 43 115 10 87
D VO2max (ml/min) N/A N/A 230 (31) 271 (19) 244 (70) 261 (24)
D VO2max (%) N/A N/A 12.3 (1.5) 13.1 (0.9) 12.9 (3.7) 13.0 (1.2)
Data expressed as means and standard deviations.
D VO2max expressed as the change with exercise training in ml O2 per minute, reported as LS means with age, sex, and baseline VO2max as covariates. D VO2max %
reported as LS means with age and sex as covariates.
{p#0.05 indicates significant difference in VO2max training response between adverse responders and non-adverse responders.
doi:10.1371/journal.pone.0037887.t006
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data of DREW, and the results are summarized in Table 7. No
substantive differences were observed in the prevalence of ARs
among the three levels of exercise energy expenditure, which ranged
from 4 to 12 kcal/kg of body weight per week.
Another important question is that of the proportion of subjects
who experienced ARs for more than one risk factor. We tabulated
the number of participants in the six studies who registered ARs
for two or more risk factors, and the results are shown in Table 8.
Approximately 7% of sedentary adults experienced ARs for at
least two common cardiometabolic and diabetes risk factors
following exposure to regular exercise. Only a small minority of
participants (,1%) exhibited ARs for three or more traits.
Discussion
The prevalence of ARs for select risk factors varied from 8.3%
for the exercise training-induced changes in FI to 13.3% for the
changes in HDL-C, with about 7% of participants experiencing
adverse changes in two or more risk factors. This subgroup should
receive urgent attention. The prevalence of ARs appears to be
similar at low and high doses of exercise. However, we do not
know whether some adverse responders would revert to a more
positive response pattern if exposed to different exercise doses or
exercise modalities.
It is important to differentiate between ARs for risk factors for
common chronic diseases, as referred to in the present study, from
other more acute ARs such as cardiac events related to exertion
during an exercise bout [20,21,22], sudden cardiac death during or
immediately after exercise typically associated with a cardiomyop-
athy or a congenital abnormality [23], or even exercise intolerance
due to abnormal skeletal muscle energy metabolism [24]. These
events are fortunately rare among physically active people. In
contrast, ARs as defined herein for common cardiometabolic and
diabetes risk factors are much more prevalent and become evident
with exposure to regular exercise. It is not known whether such ARs
can be detected after a single or a few bouts of exercise.
Even though the presence of ARs was first detected among
completers in Blacks and Whites of the HERITAGE Family Study,
in which subjects were confirmed to be sedentary at baseline, with a
rather healthy profile, the phenomenon was confirmed in five other
exercise intervention studies. The consistency in the prevalence of
ARs across heterogeneous studies in terms of health status of
subjects at baseline and of exercise training regimen is notable.
One question that may arise is whether ARs are the result of
unwarranted exercise-drug interaction effects. The question
cannot be answered with direct experimental data at the moment,
but based on our analysis of the results of the six studies, it is highly
unlikely that it is the case. For instance, HERITAGE and
JYVASKYLA subjects were healthy adults taking no medication
for high blood pressure, hypercholesterolemia, or hyperglycemia.
However, many subjects in DREW, INFLAME, MARYLAND,
and STRRIDE were taking medications for high blood pressure,
Table 7. Adverse and Excellent Responders to Regular Exercise in DREW*.
DREW
4 kcal/kg/wk
DREW
8 kcal/kg/wk
DREW
12 kcal/kg/wk
N subjects 143 89 94
ADVERSE RESPONDERS N % N % N %
D Fasting insulin N$24 pmol/L 16 11 9 10 11 12
D HDL-C N#0.12 mmol/L 35 25 21 24 31 33
D Triglycerides N$0.42 mmol/L 19 13 14 16 18 19
D SBP N$10 mm Hg 32 22 14 16 12
*A postmenopausal woman who follows the 2008 Physical Activity Guidelines for Americans expends about 8 kcal/kg/week in her exercise program. The 4 kcal/kg/week
is about 50% the current recommendation whereas the 12 kcal/kg/week is about 50% above the recommended dose.
doi:10.1371/journal.pone.0037887.t007
Table 8. Percentage of Subjects in Each Study with 1, 2, or 3 and More Adverse Responses.
1 Adverse Response 2 Adverse Responses 3 or 4 Adverse Responses
N % N % N %
HERITAGE
Blacks 51 20% 11 4% 0 0%
Whites 94 20% 17 4% 3 1%
DREW 131 40% 37 11% 9 3%
INFLAME 32 46% 9 13% 1 1%
STRRIDE 71 24% 9 3% 0 0%
MARYLAND 54 34% 5 3% 0 0%
JYVASKYLA 35 33% 7 7% 0 0%
TOTALS (mean %) 468 31% 95 6% 13 0.8%
The four traits considered were the exercise training-induced changes in fasting insulin, HDL-cholesterol, triglycerides, and resting systolic blood pressure.
doi:10.1371/journal.pone.0037887.t008
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hyperglycemia, or dyslipoproteinemia. Yet substantial numbers of
subjects with or without medication in these cohorts experienced
one or more ARs.
The challenge is now to investigate whether baseline predictors
of ARs can be identified to screen individuals at risk so that they
can be offered alternative approaches to modifying cardiometa-
bolic risk factors. Research based on HERITAGE has amply
demonstrated that the response pattern to exercise training
aggregates in families [25,26,27,28]. In fact, the heritability of
the changes induced by the exercise program reached about 30%
for plasma HDL-C and TG [26] and about 20% to 25% for
indicators of insulin metabolism and resting SBP [29,30]. There
are strong indications from a baseline skeletal muscle gene
expression profile and from a genome-wide association study
performed on the Whites of HERITAGE that the genetic
component of a response trait can be defined in terms of RNA
abundance observed in the sedentary state or by specific genomic
variants [31,32,33]. This suggests that it may be possible with
further research to identify molecular predictors of the inability to
benefit from regular exercise and of adverse changes in specific
cardiometabolic and diabetes risk factors.
In summary, we did not find any evidence for differences in the
prevalence of ARs between Blacks and Whites or between men
and women. Moreover, the AR traits are not explained by prior
health status of subjects, age, amount of exercise imposed by the
program, or lack of improvement in cardiorespiratory fitness. No
evidence could be found for the hypothesis that ARs were the
result of drug-exercise interactions. Thus, some individuals
experience ARs when exposed to regular exercise, but the causes
of the phenomenon are unknown at this time. The observations
reported herein need to be extended to other cardiometabolic and
diabetes risk factors such as LDL-cholesterol, small, dense LDL
particles, markers of low-grade inflammation, adiposity traits, and
ectopic fat depots. We conclude that it is critical to search for
potential physiological and molecular predictors so that individuals
at risk for adverse response patterns can be identified and offered
proper guidance in an exercise medicine preventive or therapeutic
context.
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